PROVECTUS BIOPHARMACEUTICALS, INC. announced that it will receive $10,000,000 in funding on July 16, 2024. The company will issue convertible debt in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1189 USD | +10.09% | -8.54% | +23.85% |
1st Jan change | Capi. | |
---|---|---|
+23.85% | 49.88M | |
+20.03% | 126B | |
+23.61% | 117B | |
+23.03% | 27.52B | |
-18.07% | 20.87B | |
-13.94% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- PVCT Stock
- News Provectus Biopharmaceuticals, Inc.
- Provectus Biopharmaceuticals, Inc. announced a financing transaction